Taris Biomedical hired Sarma Duddu to be its new president and CEO.
The Lexington, Mass.-based durg/device developer said Duddu brings 15 years of pharmaceutical industry experience to the corner office, where he’ll start immediately.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Taris Biomedical hired Sarma Duddu to be its new president and CEO.
The Lexington, Mass.-based durg/device developer said Duddu brings 15 years of pharmaceutical industry experience to the corner office, where he’ll start immediately.
Thermo Fisher Scientific Inc. (NYSE:TMO) closed its $260 million deal to acquire Fermentas International Inc.
Burlington, Ont.-based Fermentas, which runs its principal operation out of Vilnius, Lithuania, makes enzymes, reagents and molecular weight markers. The company, which employs about 500 workers, posted sales of about $55 million last year.
Thermo Fisher said it integrate Fermentas into its analytical technologies division.
Biomet Inc. bought out Braintree, Mass.-based Cytosol Laboratories Inc.
The Warsaw, Ind.-based firm manufactures reconstructive products for musculoskeletal applications in both surgical and non-surgical treatments. The company plans to incorporate Cytosol’s anticoagulants and other blood component processing products into its product lines.
GE Healthcare’s second-quarter revenues and profits showed continued growth during the three months ended June 30.
The medical equipment manufacturing unit of General Electric Co. (NYSE:GE) generated $4.1 billion in revenues during the quarter, a 3 percent increase over the previous year’s second quarter. Segment profit jumped 12 percent to $661 million, compared with $590 million during Q2 2009.
Some of the segment’s recent sales growth is attributable to the sharp decline in hospital spending in early 2009.
In a previous post, I addressed the importance of location to a media plan. The most clever advertising in the world won’t be effective if the wrong people see it due to its location. Equally important to location, or “reach,” as it’s known in advertising circles, is frequency. It stands to reason that the more often you see something, the more memorable it will be.
It’s been a busy week for everyone concerned with a proposed, $1.6 billion merger between Charles River Laboratories International Inc. (NYSE: CRL) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX).
Aiming to counter stiff opposition from some of its top institutional investors, Charles River Labs issued a revised presentation this week highlighting the benefits of the deal and touted a proxy advisory firm’s support for the merger.
MedTech Group Inc. brought Advanced Polymers Inc. into its family of companies.
South Plainfield, N.J.-based MedTech Group acquired the Salem, N.H.-based company in an effort to bolster its contract design operations specifically for catheter based devices, according to a press release.
By MedCity News
By Chris Seper
Three Pennsylvania companies — a diagnostics business, an imaging company and another creating a treatment for head lice — were among nine businesses to receive a share of $1.8 million from Ben Franklin Technology Partners of Southeastern Pennsylvania.
Inverness Medical Innovations, Inc. (NYSE:IMA) gave itself a makeover at a July 14 shareholder meeting.
Company stockholders approved the company’s name change to Alere Inc. (NYSE:ALR).
The Waltham, Mass.-based diagnostics firm created the brand Alere in 2008 after acquiring Alere Medical, ParadigmHealth and Matria Healthcare and merging them under a single umbrella. The company said it expects its NYSE stock symbol to change from IMA to ALR July 19.
Surgical instruments maker NuOrtho Surgical Inc. won 510(k) clearance from the Food & Drug Administration for its Ceruleau electrosurgical probe.
The device is the first of the Fall River, Mass.-based company’s tissue preservation surgical tools. The Ceruleau is a 3.5mm arthroscopic radio frequency electrosurgical probe designed to use low-level radio frequencies to smooth and contour frayed or torn cartilage while avoiding damage to adjacent cartilage, according to a press release.
Medical device reprocessor SterilMed Inc. was bought by two private equity firms for an undisclosed sum.
The company’s new owners are Boston-based Great Hill Partners and Cleveland-based Primus Capital Funds, according to a press release.